AzTrials
AzTrials

Elderly InpatientsHOSPISENIORNCT06098534

Evaluation of a Prototype for an Innovative Room for the Elderly

A study testing Hospi'Senior and Conventional room in people with Elderly Inpatients, run by University Hospital, Angers at 5 sites in France.

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

The Groupement de Coopération Sanitaire des Hôpitaux Universitaires du Grand Ouest (GCS HUGO) (health cooperation group for university hospitals in the west of France), is proposing to improve the quality of geriatric care by modernizing hospital rooms. Read more about this study

Who is it for?
Ages 75 years and older
Conditions the study is for
Elderly Inpatients
What is being tested?
Hospi'Senior and Conventional room
Could I receive a placebo?
No, everyone receives an active treatment
How many people
200 participants
Where
5 sitesFrance
Study dates
9 Nov 2023to 10 Feb 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 75 years and older
  • All sexes
  • No healthy volunteers
  • Older adult

Who may be able to join

  • Age ≥ 75 years
  • Admission in a short-stay geriatric department following initial emergency care department or direct entry from home
  • Hospitalization in single room: Hospi'Senior or conventional
  • Affiliation to a social security scheme
  • Informed consent to participate in the study from the patient or his/her representative (tutor/curator if applicable, or in order of priority a trusted person, the family or a person with whom the person concerned has a close and stable relationship)

Who cannot join

  • Contraindication to study participation at the discretion of the medical team
  • Hospitalization for more than 3 days (>3 days) in the short-stay geriatric unit
  • Hospitalization in a double room
  • Planned hospitalization
  • Poor understanding of the French language
  • Patient under safeguard of justice

Trial locations and contacts

5 sites in 1 country. Contact the study team or a site near you to ask about taking part.

5 sites in 1 country

France5 sites, 5 recruiting
  • Angers University Hospital

    Angers, 49933

    Cédric ANNWEILER, MD, PhD

    Recruiting
  • Brest University Hospital

    Brest, 29200

    Armelle GENTRIC, MD, PhD

    Recruiting
  • Nantes University Hospital

    Nantes, 44093

    Guillaume CHAPELET, MD

    Recruiting
  • Rennes University Hospital

    Rennes, 35033

    Aline CORVOL, MD

    Recruiting
  • Tours University Hospital

    Tours, 37044

    Wassim GANA, MD

    Recruiting

Other trials in France

About this study

Official title: Evaluation d'un Prototype de Chambre Innovante adaptée au Grand Age

The Groupement de Coopération Sanitaire des Hôpitaux Universitaires du Grand Ouest (GCS HUGO) (health cooperation group for university hospitals in the west of France), is proposing to improve the quality of geriatric care by modernizing hospital rooms. The GCS HUGO has embarked on a project to co-design a hospital room adapted for the elderly, called "Hospi'Senior", with the help of the "Dépendance et Grand âge" (Dependency and Old Age) steering committee, made up of experts from HUGO's establishments and experts from several companies.

Read the detailed description

The main objective is to evaluate the effect of hospitalization in a Hospi'Senior room on the length of stay of elderly people compared with hospitalization in a conventional room for a similar admission reason.

The secondary objectives are to evaluate the effect of hospitalization in a Hospi'Senior room for elderly people, compared with hospitalization in a conventional room for a similar admission reason, on :

  1. Changes in functional abilities during the hospital stay and in the 30 days following discharge from the short-stay geriatric unit 3) Occurrence of behavioral disorders 4) Occurrence of falls during the hospital stay and in the 30 days following discharge from the short-stay geriatric unit 5) Occurrence and/or worsening of stage bedsores ≥ 2 during the hospital stay as classified by the National Pressure Ulcer Advisory Panel (NPUAP) 6) Occurrence of early rehospitalization
Being tested
Hospi'Senior, Conventional room
Keywords
Prototype, Care, Hospital Room, Elderly, Innovation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hospi'SeniorBehavioural

    The Hospi'Senior room is equipped with conventional furnishings (same bed and same armchair as a conventional room) to which have been added technological innovations and innovations in furnishings. Innovative technologies cover bed equipment, patient mobility (autonomous and assisted), lighting, communication and social space.

  • Conventional roomBehavioural

    The conventional room is a classic hospital room not equipped with the innovative technologies found in the Hospi'Senior room.

    The room is equipped with a bed, bedside table, adjustable bed table with castors and an armchair.

Study groups in NCT06098534
Study groupRoleWhat they receive
"Hospi'Senior" groupExperimentalPatients admitted to the Hospi'Senior room benefit from the innovative technologies available in this room. Patients benefit from standard care throughout their hospital stay.
Receives: Behavioral: Hospi'Senior
"Conventional room" groupExperimentalPatients admitted to a conventional room receive the standard care throughout their hospital stay.
Receives: Behavioral: Conventional room

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Length of stay in the short-stay geriatric unit

    The length of stay is measured in days

    Measured: This outcome is assessed at the end of the geriatric unit stay (up to 2 months)

Secondary outcomes (5)
  1. Changes in functional capabilities

    Functional capabilities are assessed with Activities of Daily Living (ADL) score.

    ADL is an autonomy assessment grid (from 0 to 6) for basic activities of daily living. The lower the score, the more dependent the patient is.

    Measured: This outcome is assessed at inclusion, on discharge (up to 2 months) and within 30 days of discharge from the short-stay geriatric unit

  2. Occurrence of behavioral disorders

    Behavioral disorders are assessed with Neuropsychiatric Inventory-nursing home version (NPI-NH) score.

    For each scale domain, higher scores indicate greater neuropsychiatric symptomatology (range from 0 to 12/12).

    Measured: This outcome is assessed at inclusion and on discharge (up to 2 months)

  3. Occurrence of falls

    Number of falls observed during hospital stay and within 30 days of discharge from the short-stay geriatric unit

    Measured: This outcome is assessed on discharge (up to 2 months) and within 30 days of discharge from the short-stay geriatric unit

  4. Occurrence and/or worsening of stage bedsores ≥ 2

    Occurrence and/or worsening of stage bedsores ≥ 2 during hospital stay

    Measured: This outcome is assessed on discharge (up to 2 months)

  5. Occurrence of early rehospitalization

    Number of unscheduled hospitalization in a Medicine-Surgery-Obstetrics (MSO) unit within 30 days of discharge from the short-stay geriatric unit

    Measured: This outcome is assessed within 30 days of discharge from the short-stay geriatric unit

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Oct 2023
  2. Study start9 Nov 2023
  3. Primary completion10 Feb 2028 (estimated)
  4. Study completion10 Feb 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Non-randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
200 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06098534
Sponsor's protocol ID
49RC23_0276
Acronym
HOSPISENIOR
Status last verified
Jun 2026
First submitted
11 Oct 2023
Last updated
29 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Carcreff L, Briere O, Chapelet G, Fougere B, Gentric A, Somme D, Paolantoni F, Gaudin F, Annweiler C, Noublanche F. User experience of innovative hospital rooms for older patients: the HospiSenior project. Geriatr Psychol Neuropsychiatr Vieil. 2025 Dec 1;23(4):458-467. doi: 10.1684/pnv.2025.1254.

    PubMed 41627010

Questions about this trial

What is this clinical trial studying?

A study testing Hospi'Senior and Conventional room in people with Elderly Inpatients, run by University Hospital, Angers at 5 sites in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 29 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Olivier BRIERE, MD (+33 2 41 35 47 25, olivier.briere@chu-angers.fr), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Length of stay in the short-stay geriatric unit (time frame: This outcome is assessed at the end of the geriatric unit stay (up to 2 months)). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06098534, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 29 Jun 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in